UK buys potential COVID-19 vaccines from J&J and Novavax

LONDON, Aug 14 (Reuters) - The UK government has sealed two
more deals to secure COVID-19 vaccines, buying shots in
development from U.S. drugmakers Johnson & Johnson and
Novavax Inc, the chair of the UK Vaccine Taskforce
Katie Bingham told Sky News on Friday.

In a separate statement, Novavax said the UK would buy 60
million doses of its coronavirus vaccine candidate, NVX-CoV2373,
for a phase 3 clinical trial in the country.
(Reporting by Alistair Smout; Writing by Josephine Mason;
Editing by Jan Harvey)